October 17, 2016 (CNBC)
Arie Belldegrun, Kite Pharma CEO talks to CNBC’s Meg Tirrell about developing cancer immunotherapy drugs with T-cells. Also Belldegrun address the question about pricing the product once it comes to market.
VIDEO: Interview with Arie Belldegrun, Kite Pharma CEO on pricing
